An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)

NCT01483326 · clinicaltrials.gov ↗
COMPLETED
Status
215
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche